Sergio Gianfranco Dompé

Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Dompé in 1940 and is headquartered in Milan, Italy.

Dompe Group SpA (Dompé Group SpA) operates as a holding company with interests in pharmaceutical development and medical research. It provides services through its subsidiaries such as Dompé Farmaceutici, Dompé Biotec , Dompé, Dompé International, Dompé Pharma, Biogen Dompé and Biogen Dompé AG. The company is headquartered in Milan, Italy.

Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy.

Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy

Farmindustria SA engages in the development, manufacture, and commercialization of pharmaceutical products. These include anti-ulcers, multivitamins, anti-inflammatories, muscle relaxants, neurotonics, and calcium supplements. Its brands include Bonil, Caditar, Flectadol, Hiperflex, Maxucal, Trilat, and Ulcemex. The company was founded in March 1995 and is headquartered in Lima, Peru.

Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy.

Istituto Italiano di Tecnologia engages in the scientific research for technological development. It offers mechanical workshop that carries out advisory, construction, design, prototyping, and development activities. Its research domains include robotics, nanomaterials, technologies for life sciences (lifetech), and computational sciences. The company was founded by Giulio Tremonti and Vittorio Grilli in 2003 and is headquartered in Genoa, Italy.